Cite
MLA Citation
Aaruni Saxena et al.. “Can PDL-1 levels predict response to triple regimen (carboplatin + pembrolizumab+ pemetrexed) in treatment for metastatic non-small cell lung cancer – a real world outcome study.” Lung cancer, vol. 156, n.d., pp. S37–S38. http://access.bl.uk/ark:/81055/vdc_100131047638.0x000042